A data review and re-assessment of ovarian cancer serum proteomic profiling

BMC Bioinformatics

Table 2 Development of Diagnostic Rule 2.

Consecutive M/Z	M/Z	Wilcoxon p-value	Rule 2
5534	2665.397	4.06E-09	S
6372	3534.072	1.26E-07
6753	3969.469	4E-07	S
6772	3991.844	6.87E-09	S
6782	4003.645	1.87E-12	S
6802	4027.3	6.21E-10	S
6814	4041.526	1.86E-07
6823	4052.213	8.33E-07
6827	4056.967	9.38E-07	S
6836	4067.673	3.9E-07
6852	4086.742	4.11E-07
6934	4185.17	6.56E-09
7383	4744.889	1.71E-07	S
7449	4830.124	2.89E-07
7468	4854.802	8.22E-07
7508	4906.962	5.45E-07
7606	5035.93	1.41E-07
8707	6599.823	4.96E-07
8839	6801.495	6.46E-09	S
9439	7756.437	2.66E-07
9457	7786.054	4.58E-07	S
9483	7828.934	6.23E-07
9607	8035.058	4.94E-10
9793	8349.266	2.04E-08	S
12910	14511.46	6.4E-07
13036	14796.14	3.95E-07	S
13113	14971.48	1.76E-07
13201	15173.13	7.88E-09
13537	15955.47	3.13E-07	S
13987	17034.05	4.53E-09	S

The M/Z values were sorted by M/Z values greater than 2,000 and p-values less than 10^-6. Consecutive M/Z is the numerical order of the M/Z value between 1 and 15,154. The M/Z values were then binned as described in the text, and the most significant consecutive M/Z score from each of the 30 bins was selected. M/Z values that were selected by the stepwise discriminant analysis are designated "S" in the rightmost column.

ISSN: 1471-2105